Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

ANIXA BIOSCIENCES, INC. Capital Expenditures

ANIXA BIOSCIENCES, INC. (ANIX) reported Capital Expenditures of $15.79 thousand for the 12-month period ending 2020-10-31, per its 10-K filed 2022-01-04.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2022-01-04

  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-10-31 was $0.00.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-07-31 was $0.00.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-04-30 was $1.00.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-01-31 was $15.79K.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $15.79K, a 91.00% decline from fiscal 2019.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $175.46K, a 356.87% increase from fiscal 2018.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $38.40K, a 27.22% increase from fiscal 2017.
  • ANIXA BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $30.19K, a 79.40% decline from fiscal 2016.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2020-10-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04
$0.00
derived: sum of 2 quarters · filed 2022-01-04
$1.00
derived: sum of 3 quarters · filed 2022-01-04
$15.79K
10-K · filed 2022-01-04
2020-07-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01
$1.00
derived: sum of 2 quarters · filed 2021-09-01
$15.79K
10-Q · filed 2021-09-01
$15.79K
derived: sum of 4 quarters · filed 2021-09-01
2020-04-30$1.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10
$15.79K
10-Q · filed 2021-06-10
$15.79K
derived: sum of 3 quarters · filed 2021-06-10
$15.79K
derived: sum of 4 quarters · filed 2021-06-10
2020-01-31$15.79K
10-Q · filed 2021-03-11
$15.79K
derived: sum of 2 quarters · filed 2021-03-11
$15.79K
derived: sum of 3 quarters · filed 2021-03-11
2019-10-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07
$0.00
derived: sum of 2 quarters · filed 2021-01-07
$175.46K
10-K · filed 2021-01-07
2019-07-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08
$175.46K
10-Q · filed 2020-09-08
2019-04-30$175.46K
10-Q · filed 2020-06-09
2018-10-31$6.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09
$26.59K
derived: sum of 2 quarters · filed 2020-01-09
$35.89K
derived: sum of 3 quarters · filed 2020-01-09
$38.40K
10-K · filed 2020-01-09
2018-07-31$20.04K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06
$29.34K
derived: sum of 2 quarters · filed 2019-09-06
$31.85K
10-Q · filed 2019-09-06
$45.16K
derived: sum of 4 quarters · filed 2019-09-06
2018-04-30$9.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12
$11.81K
10-Q · filed 2019-06-12
$25.12K
derived: sum of 3 quarters · filed 2019-06-12
$27.88K
derived: sum of 4 quarters · filed 2019-06-12
2018-01-31$2.52K
10-Q · filed 2019-03-13
$15.82K
derived: sum of 2 quarters · filed 2019-03-13
$18.59K
derived: sum of 3 quarters · filed 2019-03-13
$18.59K
derived: sum of 4 quarters · filed 2019-03-13
2017-10-31$13.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11
$16.07K
derived: sum of 2 quarters · filed 2019-01-11
$16.07K
derived: sum of 3 quarters · filed 2019-01-11
$30.19K
10-K · filed 2019-01-11
2017-07-31$2.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07
$2.76K
derived: sum of 2 quarters · filed 2018-09-07
$16.89K
10-Q · filed 2018-09-07
$18.76K
derived: sum of 4 quarters · filed 2018-09-07
2017-04-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-06-11
$14.12K
10-Q · filed 2018-06-11
$15.99K
derived: sum of 3 quarters · filed 2018-06-11
$19.53K
derived: sum of 4 quarters · filed 2018-06-11
2017-01-31$14.12K
10-Q · filed 2018-03-09
$15.99K
derived: sum of 2 quarters · filed 2018-03-09
$19.53K
derived: sum of 3 quarters · filed 2018-03-09
$54.63K
derived: sum of 4 quarters · filed 2018-03-09
2016-10-31$1.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09
$5.41K
derived: sum of 2 quarters · filed 2018-01-09
$40.51K
derived: sum of 3 quarters · filed 2018-01-09
$146.52K
10-K · filed 2018-01-09
2016-07-31$3.54K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08
$38.64K
derived: sum of 2 quarters · filed 2017-09-08
$144.65K
10-Q · filed 2017-09-08
$144.65K
derived: sum of 4 quarters · filed 2017-09-08
2016-04-30$35.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26
$141.11K
10-Q · filed 2017-05-26
$141.11K
derived: sum of 3 quarters · filed 2017-05-26
$141.11K
derived: sum of 4 quarters · filed 2017-05-26
2016-01-31$106.01K
10-Q · filed 2017-03-16
$106.01K
derived: sum of 2 quarters · filed 2017-03-16
$106.01K
derived: sum of 3 quarters · filed 2017-03-16
$106.01K
derived: sum of 4 quarters · filed 2017-03-16
2015-10-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08
$0.00
derived: sum of 2 quarters · filed 2016-12-08
$0.00
derived: sum of 3 quarters · filed 2016-12-08
$54.78K
10-K · filed 2016-12-08
2015-07-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19
$0.00
derived: sum of 2 quarters · filed 2016-08-19
$54.78K
10-Q · filed 2016-08-19
2015-04-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20
$54.78K
10-Q · filed 2016-05-20
2015-01-31$54.78K
10-Q · filed 2016-02-19
2014-10-31$6.68K
10-K · filed 2015-12-23
2013-07-31$1.10K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20
-$654.00
derived: sum of 2 quarters · filed 2013-09-20
$1.81K
10-Q/A · filed 2013-09-20
$1.81K
derived: sum of 4 quarters · filed 2013-09-20
2013-04-30-$1.75K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19
$714.00
10-Q/A · filed 2013-06-19
$714.00
derived: sum of 3 quarters · filed 2013-06-19
$714.00
derived: sum of 4 quarters · filed 2013-09-20
2013-01-31$2.46K
10-Q/A · filed 2013-03-25
$2.46K
derived: sum of 2 quarters · filed 2013-03-25
$2.46K
derived: sum of 3 quarters · filed 2013-09-20
$3.21K
derived: sum of 4 quarters · filed 2013-09-20
2012-10-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-01-29
$0.00
derived: sum of 2 quarters · filed 2013-09-20
$750.00
derived: sum of 3 quarters · filed 2013-09-20
$1.60K
10-K · filed 2013-01-29
2012-07-31$0.00
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20
$750.00
derived: sum of 2 quarters · filed 2013-09-20
$1.60K
10-Q/A · filed 2013-09-20
$1.60K
derived: sum of 4 quarters · filed 2013-09-20
2012-04-30$750.00
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19
$1.60K
10-Q/A · filed 2013-06-19
$1.60K
derived: sum of 3 quarters · filed 2013-06-19
$2.17K
derived: sum of 4 quarters · filed 2013-06-19
2012-01-31$850.00
10-Q/A · filed 2013-03-25
$850.00
derived: sum of 2 quarters · filed 2013-03-25
$1.43K
derived: sum of 3 quarters · filed 2013-03-25
$3.63K
derived: sum of 4 quarters · filed 2013-03-25
2011-10-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29
$575.00
derived: sum of 2 quarters · filed 2013-01-29
$2.78K
derived: sum of 3 quarters · filed 2013-01-29
$9.03K
10-K · filed 2013-01-29
2011-07-31$575.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14
$2.78K
derived: sum of 2 quarters · filed 2012-09-14
$9.03K
10-Q · filed 2012-09-14
2011-04-30$2.21K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14
$8.45K
10-Q · filed 2012-06-14
2011-01-31$6.25K
10-Q · filed 2012-03-16
2010-10-31$2.07K
10-K · filed 2012-01-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92